Biotecnología
Biotecnología
BioCity, AstraZeneca Partner on Treatment of Advanced HCC
29/09/2023 -
Will evaluate the potential for the combination of BC3402 with durvalumab to improve the clinical outcome of subjects with HCC.
Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
29/09/2023 -
SPARTA technology aims to accelerate development, manufacture and QC of nanoparticles used for gene therapies, vaccines, and cancer drugs.
Peptone Expands Leadership Team with Key Executive Hires
29/09/2023 -
Patrik Foerch appointed chief scientific officer; David Lowe, senior vice president of protein therapeutics; and Benjamin Owens, chief business officer.
Evonik Boosts Portfolio of Nanoparticle Technologies
29/09/2023 -
New nanoparticle process technology increases options for nanomedicine formulations.
Viralgen Vector Core, Elpida Partner on SPG50 and CMT4J Clinical Trials
29/09/2023 -
Aims to enable the efficient manufacture of the AAV9 based therapies for use in Elpida Tx's clinical trials.
Ono, Admid Partner on Novel Antibody Drugs in Oncology
28/09/2023 -
Ono will evaluate and develop antibody product candidates at the preclinical and clinical stages.
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4M
28/09/2023 -
Award will help Theradaptive scale up the production of its OsteoAdapt regenerative therapeutic product for spine and trauma repair.
Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
28/09/2023 -
Pfizer will leverage Ginkgo's RNA technology for the discovery and development of novel RNA molecules across priority research areas.
Flexan, ILC Dover Earn Class 7 Certification for Cleanroom in Mexico
28/09/2023 -
Nearshoring strategy supports increased customer demand while upholding stringent quality standards.
Everads, Kriya Partner on Ocular Gene Therapy Candidates
28/09/2023 -
To use Everads' suprachoroidal delivery platform that enables non-surgical delivery to the back of the eye via the suprachoroidal space.
SK pharmteco Acquires Controlling Interest in CBM
27/09/2023 -
Expands technical expertise, production capacity, and geographic reach.
Charles River Launches Lentivation Gene Therapy Manufacturing Platform
27/09/2023 -
Aims to reduce LVV manufacturing timelines for gene and gene-modified cell therapies by up to 60 percent.
CDMO C3i Center is Manufacturing a Cell Therapy Product for Europe
27/09/2023 -
C3i provides process development and manufacturing to phase 3 with the expected goal of commercial launch at the end of 2024.
Repligen Acquires Fluid Management Company Metenova
27/09/2023 -
Gains magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and CDMOs.
Merck KGaA Enters Strategic AI-driven Discovery Alliances
27/09/2023 -
Partnerships with BenevolentAI and Exscientia aimed at driving accelerated drug discovery with higher probability of success.
AcuraStem, Takeda Partner to Advance PIKFYVE Therapeutics
27/09/2023 -
Takeda will receive an exclusive license to AcuraStem’s PIKFYVE program, a therapeutic target for ALS and potentially Frontotemporal Dementia.
MedRhythms Selects Curavit for MR-001 Trial in Stroke Impairment
27/09/2023 -
Curavit is responsible for managing all aspects of MedRhythms’ hybrid decentralized clinical trial.
Chime Biologics, Kings Pharm Partner to Accelerate Biosimilar Launch
27/09/2023 -
Chime will provide cell line development, process development, global GMP manufacturing, commercialization, and regulatory filing support.
Pharmanovia Acquires Global CNS Portfolio from Sanofi
27/09/2023 -
Expands neurology portfolio with the acquisition of 11 central nervous system brands.
Valneva Signs $32M IXIARO Supply Pact with U.S. Government
27/09/2023 -
Deal includes possibility of purchasing additional doses during the next twelve months.
Charnwood Molecular Rebrands to Charnwood Discovery
27/09/2023 -
Specializes in enhancing the experience and success of complex drug discovery for clients.
